Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
5.61
+0.61 (12.20%)
At close: Dec 20, 2024, 4:00 PM
5.54
-0.07 (-1.25%)
After-hours: Dec 20, 2024, 7:50 PM EST
Sage Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -337.59 | -541.49 | -532.78 | -457.89 | 606.07 | -680.24 | |
| Depreciation & Amortization | 1.31 | 1.39 | 1.12 | 4.18 | 2.63 | 2.28 | |
| Loss (Gain) From Sale of Investments | 0.4 | -6.47 | 4.35 | -10.6 | -0.69 | -10.64 | |
| Stock-Based Compensation | 58.02 | 73.37 | 61.6 | 104.63 | 95.99 | 153.23 | |
| Change in Accounts Payable | -4.01 | -8.5 | 8.43 | 6.69 | -11.51 | -18.78 | |
| Change in Other Net Operating Assets | -38.27 | -58.89 | -2.76 | -25.2 | -28.22 | 25.44 | |
| Operating Cash Flow | -320.15 | -540.59 | -460.04 | -378.18 | 664.28 | -528.71 | |
| Capital Expenditures | 0.11 | -0.55 | -0.94 | -0.37 | -0.35 | -5.75 | |
| Investment in Securities | 262.05 | 443.47 | 326.37 | -1,002 | 443.03 | -137.41 | |
| Investing Cash Flow | 262.17 | 442.91 | 325.43 | -1,002 | 442.68 | -143.16 | |
| Issuance of Common Stock | 11.18 | 6.93 | 3.11 | 14.72 | 426.76 | 610.13 | |
| Repurchase of Common Stock | -0.66 | -0.9 | -0.04 | -1.39 | - | -2.18 | |
| Other Financing Activities | -0.12 | - | - | - | - | -0.33 | |
| Financing Cash Flow | 10.4 | 6.03 | 3.07 | 13.33 | 426.76 | 607.62 | |
| Net Cash Flow | -47.59 | -91.65 | -131.53 | -1,367 | 1,534 | -64.24 | |
| Free Cash Flow | -320.04 | -541.14 | -460.97 | -378.55 | 663.94 | -534.46 | |
| Free Cash Flow Margin | -300.79% | -625.92% | -5997.57% | -6001.17% | 59.59% | -7781.84% | |
| Free Cash Flow Per Share | -5.29 | -9.04 | -7.77 | -6.45 | 12.53 | -10.51 | |
| Levered Free Cash Flow | -217.68 | -333.05 | -272.33 | -195.97 | 448.8 | -281.74 | |
| Unlevered Free Cash Flow | -217.68 | -333.05 | -272.33 | -195.97 | 448.8 | -281.74 | |
| Change in Net Working Capital | 44.33 | 65.71 | -7.75 | 16.34 | 39.46 | -11.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.